WHO declares monkeypox a public health emergency

The World Health Organization (WHO) has declared monkeypox a public health emergency in light of thousands of cases spreading across the globe.

More than 15,000 cases have been identified worldwide, according to WHO, with more than two-thirds of cases reported in the WHO European Region. Monkeypox is a viral zoonosis with symptoms similar to those seen in the past in smallpox patients, though it is considered less severe. Monkeypox primarily occurs in central and west Africa, often in proximity to tropical rainforests, according to WHO. 

It is contracted as a result of prolonged personal contact with an infected individual (including sexual contact) or coming into contact with their contaminated belongings. Symptoms usually include: rash, spots, ulcers, or blister-like lesions anywhere on the body; swollen and painful lymph glands; and fever, headache and muscle aches, chills or exhaustion.

WHO declared monkeypox a Public Health Emergency of International Concern––the agency’s highest level of alert––on July 23. However, WHO noted that the outbreak currently only affects gay men, despite other cases among children and women.

“Although I am declaring a public health emergency of international concern, for the moment this is an outbreak that is concentrated among men who have sex with men, especially those with multiple sexual partners,” said WHO Director-General Tedros Adhanom Ghebreyesus on July 23. “That means that this is an outbreak that can be stopped with the right strategies in the right groups. It’s therefore essential that all countries work closely with communities of men who have sex with men, to design and deliver effective information and services, and to adopt measures that protect the health, human rights and dignity of affected communities.”

Recent research published in the New England Journal of Medicine (NEJM) has revealed the virus, which can be spread in ways other than sex, is primarily impacting men who have sex with other men. 

According to the Centers for Disease Control and Prevention (CDC), the U.S. leads the globe in known cases, with more than 3,400 confirmed or suspected monkeypox cases as of July 26. CDC Director Michelle Walensky, MD, MPH, announced the agency’s response to the monkeypox outbreak in the U.S., including vaccination and testing efforts, on July 22.

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.